161 related articles for article (PubMed ID: 23002054)
1. Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia.
Leblicq C; Laverdière C; Décarie JC; Delisle JF; Isler MH; Moghrabi A; Chabot G; Alos N
Pediatr Blood Cancer; 2013 May; 60(5):741-7. PubMed ID: 23002054
[TBL] [Abstract][Full Text] [Related]
2. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate treatment in children with acute lymphoblastic leukemia and osteonecrosis - radiological and clinical findings in a national cohort.
Utriainen P; Niinimäki TT; Huurre AJ; Vepsäläinen KL; Mäkitie OM; Niinimäki RA
Acta Oncol; 2021 Sep; 60(9):1140-1145. PubMed ID: 34309491
[No Abstract] [Full Text] [Related]
5. Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia--two-year outcomes.
Nguyen T; Zacharin MR
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):161-7. PubMed ID: 16562590
[TBL] [Abstract][Full Text] [Related]
6. QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?
Amin NL; James RM; Phillips R
Arch Dis Child; 2016 Mar; 101(3):287-90. PubMed ID: 26768828
[No Abstract] [Full Text] [Related]
7. Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemia.
Marchese VG; Connolly BH; Able C; Booten AR; Bowen P; Porter BM; Rai SN; Hancock ML; Pui CH; Howard S; Neel MD; Kaste SC
Phys Ther; 2008 Mar; 88(3):341-50. PubMed ID: 18202079
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
9. Transient migratory osteoporosis: rapid response to pamidronate treatment.
Carty S; Herdman G; Williams F; Srinivasan U
J Clin Rheumatol; 2007 Jun; 13(3):138-9. PubMed ID: 17551379
[TBL] [Abstract][Full Text] [Related]
10. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates.
Malmgren B; Aström E; Söderhäll S
J Oral Pathol Med; 2008 Apr; 37(4):196-200. PubMed ID: 18321345
[TBL] [Abstract][Full Text] [Related]
11. Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis.
Padhye B; Dalla-Pozza L; Little DG; Munns CF
Pediatr Blood Cancer; 2013 Sep; 60(9):1539-45. PubMed ID: 23625773
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer.
Jäger M; Zilkens C; Westhoff B; Jelinek EM; Kozina G; Krauspe R
Anticancer Res; 2009 Aug; 29(8):3433-40. PubMed ID: 19661369
[TBL] [Abstract][Full Text] [Related]
13. Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders.
Wagner S; Poirot I; Vuillerot C; Berard C
Ann Phys Rehabil Med; 2011 Sep; 54(6):348-58. PubMed ID: 21840280
[TBL] [Abstract][Full Text] [Related]
14. Curing acute lymphoblastic leukemia and avoiding osteonecrosis: can't we have it all?
Ducassou S; Pérel Y
Pediatr Blood Cancer; 2013 May; 60(5):713-4. PubMed ID: 23335158
[No Abstract] [Full Text] [Related]
15. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns.
Karimova EJ; Rai SN; Ingle D; Ralph AC; Deng X; Neel MD; Howard SC; Pui CH; Kaste SC
AJR Am J Roentgenol; 2006 Feb; 186(2):477-82. PubMed ID: 16423956
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
18. Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia.
Vora A
Br J Haematol; 2011 Dec; 155(5):549-60. PubMed ID: 22077340
[TBL] [Abstract][Full Text] [Related]
19. Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood.
Werner A; Jäger M; Schmitz H; Krauspe R
Klin Padiatr; 2003; 215(6):332-7. PubMed ID: 14677098
[TBL] [Abstract][Full Text] [Related]
20. [MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia].
Engelbrecht V; Scherer A; Bruder M; Körholz D; Mödder U
Rofo; 2000 Apr; 172(4):336-41. PubMed ID: 10961217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
